Metabolic interactions with cancer epigenetics

Molecular Aspects of Medicine

Volumn 54, Issue , 2017, Pages 50-57

  Gao, Xia ^a   Reid, Michael A ^b   Kong, Mei ^b   Locasale, Jason W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acetyl CoA; Methionine; One carbon metabolism; S Adenosyl methionine; Serine; Ketoglutarate

Indexed keywords

2 OXOGLUTARIC ACID; 3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A; ACYL COA SYNTHETASE SHORT CHAIN FAMILY MEMBER 2; ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; BUTYRIC ACID; DNA METHYLTRANSFERASE; FUMARATE HYDRATASE; GLUTAMATE DEHYDROGENASE; GLYCINE; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE MYST; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 1; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; ISOCITRATE DEHYDROGENASE 3; LONG CHAIN FATTY ACID COENZYME A LIGASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHOGLYCERATE DEHYDROGENASE; S ADENOSYLMETHIONINE; SERINE; SPERMIDINE; SPERMINE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; HISTONE;

CELL METABOLISM; DNA DEMETHYLATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE OVEREXPRESSION; HISTONE ACETYLATION; HISTONE DEMETHYLATION; HISTONE METHYLATION; HUMAN; MALIGNANT NEOPLASM; METABOLISM; NONHUMAN; REVIEW; SERINE GLYCINE AND ONE CARBON METABOLISM; ANIMAL; BIOLOGICAL MODEL; GENETIC EPIGENESIS; GENETICS; METABOLOME; NEOPLASM;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; METABOLOME; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84994497591     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.09.001     Document Type: Review

References (107)

1. Albaugh, B.N., Arnold, K.M., Denu, J.M., KAT(ching) metabolism by the tail: insight into the links between lysine acetyltransferases and metabolism. Chembiochem 12:2 (2011), 290–298.
2. Anderson, O.S., Sant, K.E., Dolinoy, D.C., Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem 23:8 (2012), 853–859.
3. Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer 11:10 (2011), 726–734.
4. Beaudin, A.E., Abarinov, E.V., Malysheva, O., Perry, C.A., Caudill, M., Stover, P.J., Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. Am. J. Clin. Nutr 95:1 (2012), 109–114.
5. Borger, D.R., Tanabe, K.K., Fan, K.C., Lopez, H.U., Fantin, V.R., Straley, K.S., et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17:1 (2012), 72–79.
6. Boroughs, L.K., DeBerardinis, R.J., Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol 17:4 (2015), 351–359.
7. Cai, L., Sutter, B.M., Li, B., Tu, B.P., Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42:4 (2011), 426–437.
8. Caramazza, D., Lasho, T.L., Finke, C.M., Gangat, N., Dingli, D., Knudson, R.A., et al. IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 24:12 (2010), 2120–2122.
9. Carey, B.W., Finley, L.W., Cross, J.R., Allis, C.D., Thompson, C.B., Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518:7539 (2015), 413–416.
10. Carrer, A., Wellen, K.E., Metabolism and epigenetics: a link cancer cells exploit. Curr. Opin. Biotechnol 34 (2015), 23–29.
11. Cavuoto, P., Fenech, M.F., A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat. Rev 38:6 (2012), 726–736.
12. Chalkiadaki, A., Guarente, L., The multifaceted functions of sirtuins in cancer. Nat. Rev. Cancer 15:10 (2015), 608–624.
13. Chen, Z.H., Zhang, H., Savarese, T.M., Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res 56:5 (1996), 1083–1090.
14. Cluntun, A.A., Huang, H., Dai, L., Liu, X., Zhao, Y., Locasale, J.W., The rate of glycolysis quantitatively mediates specific histone acetylation sites. Cancer Metab, 3, 2015, 10.
15. Comerford, S.A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A.K., et al. Acetate dependence of tumors. Cell 159:7 (2014), 1591–1602.
16. Dalziel, K., Isocitrate dehydrogenase and related oxidative decarboxylases. FEBS Lett 117:Suppl. (1980), K45–K55.
17. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:7274 (2009), 739–744.
18. Dang, L., Jin, S., Su, S.M., IDH mutations in glioma and acute myeloid leukemia. Trends Mol. Med 16:9 (2010), 387–397.
19. Davidson, S.M., Papagiannakopoulos, T., Olenchock, B.A., Heyman, J.E., Keibler, M.A., Luengo, A., et al. Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer. Cell Metab 23:3 (2016), 517–528.
20. Dawson, M.A., Kouzarides, T., Cancer epigenetics: from mechanism to therapy. Cell 150:1 (2012), 12–27.
21. Ding, W., Smulan, L.J., Hou, N.S., Taubert, S., Watts, J.L., Walker, A.K., s-adenosylmethionine levels govern innate immunity through distinct methylation-dependent pathways. Cell Metab 22:4 (2015), 633–645.
22. Donohoe, D.R., Collins, L.B., Wali, A., Bigler, R., Sun, W., Bultman, S.J., The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48:4 (2012), 612–626.
23. Donohoe, D.R., Holley, D., Collins, L.B., Montgomery, S.A., Whitmore, A.C., Hillhouse, A., et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 4:12 (2014), 1387–1397.
24. Edmunds, L.R., Sharma, L., Kang, A., Lu, J., Vockley, J., Basu, S., et al. c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate. J. Biol. Chem, 290(33), 2015, 20100.
25. Farber, S., Diamond, L.K., Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N. Engl. J. Med 238:23 (1948), 787–793.
26. Feinberg, A.P., Tycko, B., The history of cancer epigenetics. Nat. Rev. Cancer 4:2 (2004), 143–153.
27. Feinberg, A.P., Vogelstein, B., Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:5895 (1983), 89–92.
28. Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18:6 (2010), 553–567.
29. Friso, S., Choi, S.W., Girelli, D., Mason, J.B., Dolnikowski, G.G., Bagley, P.J., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U.S.A. 99:8 (2002), 5606–5611.
30. Gama-Sosa, M.A., Slagel, V.A., Trewyn, R.W., Oxenhandler, R., Kuo, K.C., Gehrke, C.W., et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11:19 (1983), 6883–6894.
31. Gemmati, D., Ongaro, A., Scapoli, G.L., Della Porta, M., Tognazzo, S., Serino, M.L., et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol. Biomarkers Prev 13:5 (2004), 787–794.
32. Gut, P., Verdin, E., The nexus of chromatin regulation and intermediary metabolism. Nature 502:7472 (2013), 489–498.
33. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144:5 (2011), 646–674.
34. Henry, R.A., Kuo, Y.M., Bhattacharjee, V., Yen, T.J., Andrews, A.J., Changing the selectivity of p300 by acetyl-CoA modulation of histone acetylation. ACS Chem. Biol 10:1 (2015), 146–156.
35. Hensley, C.T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., et al. Metabolic heterogeneity in human lung tumors. Cell 164:4 (2016), 681–694.
36. Hoffman, R.M., Methionine dependence in cancer cells – a review. In Vitro 18:5 (1982), 421–428.
37. Huang, Z., Cai, L., Tu, B.P., Dietary control of chromatin. Curr. Opin. Cell Biol 34 (2015), 69–74.
38. Jiang, Y., Qian, X., Shen, J., Wang, Y., Li, X., Liu, R., et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol 17:9 (2015), 1158–1168.
39. Johnson, C., Warmoes, M.O., Shen, X., Locasale, J.W., Epigenetics and cancer metabolism. Cancer Lett 356:2 Pt A (2015), 309–314.
40. Kabil, O., Vitvitsky, V., Banerjee, R., Sulfur as a signaling nutrient through hydrogen sulfide. Annu. Rev. Nutr 34 (2014), 171–205.
41. Kaelin, W.G. Jr., McKnight, S.L., Influence of metabolism on epigenetics and disease. Cell 153:1 (2013), 56–69.
42. Karikari, C.A., Mullendore, M., Eshleman, J.R., Argani, P., Leoni, L.M., Chattopadhyay, S., et al. Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers. Mol. Cancer Ther 4:12 (2005), 1860–1866.
43. Killian, J.K., Kim, S.Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov 3:6 (2013), 648–657.
44. Kohli, R.M., Zhang, Y., TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:7472 (2013), 472–479.
45. Kryukov, G.V., Wilson, F.H., Ruth, J.R., Paulk, J., Tsherniak, A., Marlow, S.E., et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science, 351(6278), 2016.
46. Langer, M.R., Fry, C.J., Peterson, C.L., Denu, J.M., Modulating acetyl-CoA binding in the GCN5 family of histone acetyltransferases. J. Biol. Chem 277:30 (2002), 27337–27344.
47. Lee, J.V., Carrer, A., Shah, S., Snyder, N.W., Wei, S., Venneti, S., et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab 20:2 (2014), 306–319.
48. Letouze, E., Martinelli, C., Loriot, C., Burnichon, N., Abermil, N., Ottolenghi, C., et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23:6 (2013), 739–752.
49. Li, M., Li, C., Allen, A., Stanley, C.A., Smith, T.J., The structure and allosteric regulation of mammalian glutamate dehydrogenase. Arch. Biochem. Biophys 519:2 (2012), 69–80.
50. Liberti, M.V., Locasale, J.W., The Warburg effect: how does it benefit cancer cells?. Trends Biochem. Sci 41:3 (2016), 211–218.
51. Locasale, J.W., Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13:8 (2013), 572–583.
52. Losman, J.A., Kaelin, W.G. Jr., What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev 27:8 (2013), 836–852.
53. Lu, C., Thompson, C.B., Metabolic regulation of epigenetics. Cell Metab 16:1 (2012), 9–17.
54. Lu, C., Ward, P.S., Kapoor, G.S., Rohle, D., Turcan, S., Abdel-Wahab, O., et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483:7390 (2012), 474–478.
55. Lu, C., Venneti, S., Akalin, A., Fang, F., Ward, P.S., Dematteo, R.G., et al. Induction of sarcomas by mutant IDH2. Genes Dev 27:18 (2013), 1986–1998.
56. Lu, S.C., Mato, J.M., S-Adenosylmethionine in liver health, injury, and cancer. Physiol. Rev 92:4 (2012), 1515–1542.
57. Mardis, E.R., Ding, L., Dooling, D.J., Larson, D.E., McLellan, M.D., Chen, K., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med 361:11 (2009), 1058–1066.
58. Martinez-Chantar, M.L., Corrales, F.J., Martinez-Cruz, L.A., Garcia-Trevijano, E.R., Huang, Z.Z., Chen, L., et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16:10 (2002), 1292–1294.
59. Martinez-Chantar, M.L., Vazquez-Chantada, M., Ariz, U., Martinez, N., Varela, M., Luka, Z., et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 47:4 (2008), 1191–1199.
60. Mashimo, T., Pichumani, K., Vemireddy, V., Hatanpaa, K.J., Singh, D.K., Sirasanagandla, S., et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159:7 (2014), 1603–1614.
61. Matsuo, K., Suzuki, R., Hamajima, N., Ogura, M., Kagami, Y., Taji, H., et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97:10 (2001), 3205–3209.
62. Mavrakis, K.J., McDonald, E.R. 3rd, Schlabach, M.R., Billy, E., Hoffman, G.R., deWeck, A., et al. Disordered methionine metabolism in MTAP/CDKN2A deleted cancers leads to dependence on PRMT5. Science 351:6278 (2016), 1208–1213.
63. McBrian, M.A., Behbahan, I.S., Ferrari, R., Su, T., Huang, T.W., Li, K., et al. Histone acetylation regulates intracellular pH. Mol. Cell 49:2 (2013), 310–321.
64. Mehrmohamadi, M., Liu, X., Shestov, A.A., Locasale, J.W., Characterization of the usage of the serine metabolic network in human cancer. Cell Rep 9:4 (2014), 1507–1519.
65. Mentch, S.J., Locasale, J.W., One-carbon metabolism and epigenetics: understanding the specificity. Ann. N. Y. Acad. Sci 1363 (2015), 91–98.
66. Mentch, S.J., Mehrmohamadi, M., Huang, L., Liu, X., Gupta, D., Mattocks, D., et al. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Cell Metab 22:5 (2015), 861–873.
67. Meynet, O., Ricci, J.E., Caloric restriction and cancer: molecular mechanisms and clinical implications. Trends Mol. Med 20:8 (2014), 419–427.
68. Morgan, H.D., Santos, F., Green, K., Dean, W., Reik, W., Epigenetic reprogramming in mammals. Hum. Mol. Genet 14 (2005), R47–R58 Spec No 1.
69. Mosammaparast, N., Shi, Y., Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem 79 (2010), 155–179.
70. Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N.G., Strittmatter, L., Kampf, C., et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun, 5, 2014, 3128.
71. Nishikawa, K., Iwamoto, Y., Kobayashi, Y., Katsuoka, F., Kawaguchi, S., Tsujita, T., et al. DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway. Nat. Med 21:3 (2015), 281–287.
72. Noushmehr, H., Weisenberger, D.J., Diefes, K., Phillips, H.S., Pujara, K., Berman, B.P., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:5 (2010), 510–522.
73. Pavlova, N.N., Thompson, C.B., The emerging hallmarks of cancer metabolism. Cell Metab 23:1 (2016), 27–47.
74. Plass, C., Pfister, S.M., Lindroth, A.M., Bogatyrova, O., Claus, R., Lichter, P., Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet 14:11 (2013), 765–780.
75. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet 14:15 (2005), 2231–2239.
76. Rakheja, D., Konoplev, S., Medeiros, L.J., Chen, W., IDH mutations in acute myeloid leukemia. Hum. Pathol 43:10 (2012), 1541–1551.
77. Reid, M.A., Wang, W.I., Rosales, K.R., Welliver, M.X., Pan, M., Kong, M., The B55alpha subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol. Cell 50:2 (2013), 200–211.
78. Roessler, M., Rollinger, W., Palme, S., Hagmann, M.L., Berndt, P., Engel, A.M., et al. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res 11:18 (2005), 6550–6557.
79. Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science 340:6132 (2013), 626–630.
80. Sadhu, M.J., Guan, Q., Li, F., Sales-Lee, J., Iavarone, A.T., Hammond, M.C., et al. Nutritional control of epigenetic processes in yeast and human cells. Genetics 195:3 (2013), 831–844.
81. Schug, Z.T., Peck, B., Jones, D.T., Zhang, Q., Grosskurth, S., Alam, I.S., et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27:1 (2015), 57–71.
82. Sharma, S., Kelly, T.K., Jones, P.A., Epigenetics in cancer. Carcinogenesis 31:1 (2010), 27–36.
83. Shen, H., Laird, P.W., Interplay between the cancer genome and epigenome. Cell 153:1 (2013), 38–55.
84. Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:6116 (2013), 211–214.
85. Shiraki, N., Shiraki, Y., Tsuyama, T., Obata, F., Miura, M., Nagae, G., et al. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab 19:5 (2014), 780–794.
86. Shyh-Chang, N., Locasale, J.W., Lyssiotis, C.A., Zheng, Y., Teo, R.Y., Ratanasirintrawoot, S., et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339:6116 (2013), 222–226.
87. Stern, L.L., Mason, J.B., Selhub, J., Choi, S.W., Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev 9:8 (2000), 849–853.
88. Suva, M.L., Riggi, N., Bernstein, B.E., Epigenetic reprogramming in cancer. Science 339:6127 (2013), 1567–1570.
89. Takahashi, H., McCaffery, J.M., Irizarry, R.A., Boeke, J.D., Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell 23:2 (2006), 207–217.
90. Tan, M., Luo, H., Lee, S., Jin, F., Yang, J.S., Montellier, E., et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146:6 (2011), 1016–1028.
91. Thomas, T., Thomas, T.J., Polyamine metabolism and cancer. J. Cell. Mol. Med 7:2 (2003), 113–126.
92. Towbin, B.D., Gonzalez-Aguilera, C., Sack, R., Gaidatzis, D., Kalck, V., Meister, P., et al. Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150:5 (2012), 934–947.
93. Turcan, S., Rohle, D., Goenka, A., Walsh, L.A., Fang, F., Yilmaz, E., et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483:7390 (2012), 479–483.
94. Ulanovskaya, O.A., Zuhl, A.M., Cravatt, B.F., NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol 9:5 (2013), 300–306.
95. Wagner, G.R., Payne, R.M., Widespread and enzyme-independent Nepsilon-acetylation and Nepsilon-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem 288:40 (2013), 29036–29045.
96. Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science 340:6132 (2013), 622–626.
97. Ward, P.S., Thompson, C.B., Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:3 (2012), 297–308.
98. Waterborg, J.H., Dynamics of histone acetylation in vivo. A function for acetylation turnover?. Biochem. Cell Biol 80:3 (2002), 363–378.
99. Wellen, K.E., Thompson, C.B., A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol 13:4 (2012), 270–276.
100. Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., Thompson, C.B., ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:5930 (2009), 1076–1080.
101. Wu, H., Zhang, Y., Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156:1–2 (2014), 45–68.
102. Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26:12 (2012), 1326–1338.
103. Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.H., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19:1 (2011), 17–30.
104. Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med 360:8 (2009), 765–773.
105. Yun, J., Johnson, J.L., Hanigan, C.L., Locasale, J.W., Interactions between epigenetics and metabolism in cancers. Front. Oncol, 2, 2012, 163.
106. Zhang, Y., Tang, Z.H., Ren, Z., Qu, S.L., Liu, M.H., Liu, L.S., et al. Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Mol. Cell. Biol 33:6 (2013), 1104–1113.
107. Zheng, Y., Thomas, P.M., Kelleher, N.L., Measurement of acetylation turnover at distinct lysines in human histones identifies long-lived acetylation sites. Nat. Commun, 4, 2013, 2203.